UnitedHealth Group will appeal an order to pay $165 million in penalties and restitution after a judge found a business acquired by the Eden Prairie-based insurer more than five years ago used deceptive practices to sell benefits that supplement traditional health insurance in Massachusetts.
The judge’s order, announced this month by the attorney general in Massachusetts, was issued in late December.
The case dealt with allegations of cheating consumers and violating consumer protection laws primarily during the years leading up to 2019, when UnitedHealth Group purchased a Texas-based company called HealthMarkets Inc. At the time, divisions of the acquired company were being investigated by regulators in Massachusetts.
“For years, the defendants preyed on financially vulnerable individuals, deceiving them into buying products they didn’t need or couldn’t afford,” Attorney General Andrea Joy Campbell said in a statement. “This order holds the companies accountable and will provide meaningful restitution to consumers.”
UnitedHealth Group said it would appeal the decision.
“We disagree with the Massachusetts court’s latest ruling in the litigation involving the HealthMarkets companies,” the company said in a statement. “The fundamental errors in this ruling compound those already made by the trial court earlier in this case and have resulted in a decision that is clearly unsupported by the evidence and contrary to established Massachusetts law.”
The case dealt with what are known as “supplemental” health plans, where patients receive a lump sum of money if they suffer certain triggering health problems.
These policies sometimes are known as “dread disease” coverage, with names like “cancer-only” or “critical illness,” where patients with certain major medical issues receive cash payouts they can use for any purpose. The benefits are distinct from health insurance policies that cover the cost of medical and hospital services and are the mainstay at UnitedHealthcare, the massive health benefits division at UnitedHealth Group.